Nita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, Jacob John, Kalpana Antony, Sunita Taneja, Nidhi Goyal, Anand Kawade, Gagandeep Kang, Sudeep Singh Rathore, Sanjay Juvekar, Jayaprakash Muliyil, Alok Arya, Hanif Shaikh, Vinod Abraham, Sudhanshu Vrati, Michael Proschan, Robert Kohberger, Georges Thiry, Roger Glass, Harry B Greenberg, George Curlin, Krishna Mohan, G V J A Harshavardhan, Sai Prasad, T S Rao, John Boslego, Maharaj Kishan Bhan
BACKGROUND: Rotavirus is the most common cause of severe dehydrating gastroenteritis in developing countries. Safe, effective, and affordable rotavirus vaccines are needed in these countries. We aimed to assess the efficacy and tolerability of a monovalent human-bovine rotavirus vaccine for severe rotavirus gastroenteritis in low-resource urban and rural settings in India. METHODS: We did a randomised double-blind, placebo-controlled, multicentre trial at three sites in Delhi (urban), Pune (rural), and Vellore (urban and rural) between March 11, 2011, and Nov 5, 2012...
June 21, 2014: Lancet